Advertisement
Screener

LIGAND PHARMACEUTICALS INCORPORATED (LGNDZ) Scorecard

2.8 / 5 stars · 68/120 Roast Me

24/120 1.0 / 5 stars All 120 Win/Lose results shown below

LGNDZ Roast Me summary

LIGAND PHARMACEUTICALS INC (LGNDZ). Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.

  • 2026-Q2: Total return Lose; Revenue growth Win; EPS growth Lose.
  • 2026-Q1: Total return Lose; Revenue growth Win; EPS growth Lose.
  • 2025-Q4: Total return Lose; Revenue growth Win; EPS growth Lose.
  • 2025-Q3: Total return Lose; Revenue growth Win; EPS growth Lose.
Trailing 1 year (4 quarters): 4 wins, 8 lossesLast fetched: 24 Sept 2026

Complete point ledger

Each cell identifies the missing side explicitly.

QuarterTotal returnRevenue growthEPS growth
2026-Q21/3 LoseLGNDZ / S&P
LGNDZ unavailable / 15.20%
WinLGNDZ / S&P
54.89% / 15.00%
LoseLGNDZ / S&P
LGNDZ unavailable / 50.40%
2026-Q11/3 LoseLGNDZ / S&P
LGNDZ unavailable / -4.33%
WinLGNDZ / S&P
51.24% / 11.30%
LoseLGNDZ / S&P
LGNDZ unavailable / 27.70%
2025-Q41/3 LoseLGNDZ / S&P
LGNDZ unavailable / 2.65%
WinLGNDZ / S&P
60.40% / 9.00%
LoseLGNDZ / S&P
LGNDZ unavailable / 13.40%
2025-Q31/3 LoseLGNDZ / S&P
LGNDZ unavailable / 8.12%
WinLGNDZ / S&P
64.83% / 4.61%
LoseLGNDZ / S&P
-19.12% / 13.45%
2025-Q21/3 LoseLGNDZ / S&P
LGNDZ unavailable / 10.94%
WinLGNDZ / S&P
40.54% / 4.83%
LoseLGNDZ / S&P
-274.89% / 10.63%
2025-Q11/3 LoseLGNDZ / S&P
LGNDZ unavailable / -4.27%
WinLGNDZ / S&P
53.40% / 4.98%
LoseLGNDZ / S&P
-234.59% / 10.57%
2024-Q41/3 LoseLGNDZ / S&P
LGNDZ unavailable / 2.41%
WinLGNDZ / S&P
27.28% / 5.25%
LoseLGNDZ / S&P
-107.48% / 6.15%
2024-Q31/3 LoseLGNDZ / S&P
LGNDZ unavailable / 5.89%
LoseLGNDZ / S&P
-0.76% / 5.89%
WinLGNDZ / S&P
206.10% / 6.11%
2024-Q21/3 LoseLGNDZ / S&P
LGNDZ unavailable / 4.28%
LoseLGNDZ / S&P
-25.82% / 5.38%
WinLGNDZ / S&P
61.54% / 5.12%
2024-Q11/3 LoseLGNDZ / S&P
LGNDZ unavailable / 10.56%
LoseLGNDZ / S&P
-41.92% / 5.71%
WinLGNDZ / S&P
325.60% / 5.59%
2023-Q40/3 LoseLGNDZ / S&P
LGNDZ unavailable / 11.69%
LoseLGNDZ / S&P
-33.09% / 6.81%
LoseLGNDZ / S&P
LGNDZ unavailable / 7.78%
2023-Q30/3 LoseLGNDZ / S&P
LGNDZ unavailable / -3.27%
LoseLGNDZ / S&P
-15.95% / 7.52%
LoseLGNDZ / S&P
LGNDZ unavailable / -5.03%
2023-Q20/3 LoseLGNDZ / S&P
LGNDZ unavailable / 8.74%
LoseLGNDZ / S&P
-4.47% / 9.50%
LoseLGNDZ / S&P
LGNDZ unavailable / -8.57%
2023-Q11/3 LoseLGNDZ / S&P
LGNDZ unavailable / 7.50%
LoseLGNDZ / S&P
-8.61% / 10.77%
WinLGNDZ / S&P
-7.41% / -15.69%
2022-Q40/3 LoseLGNDZ / S&P
LGNDZ unavailable / 7.56%
LoseLGNDZ / S&P
-18.75% / 11.88%
LoseLGNDZ / S&P
-159.82% / -17.99%
2022-Q30/3 LoseLGNDZ / S&P
LGNDZ unavailable / -4.88%
LoseLGNDZ / S&P
LGNDZ unavailable / 13.47%
LoseLGNDZ / S&P
-131.75% / -1.41%
2022-Q20/3 LoseLGNDZ / S&P
LGNDZ unavailable / -16.10%
LoseLGNDZ / S&P
LGNDZ unavailable / 13.71%
LoseLGNDZ / S&P
-117.63% / 11.04%
2022-Q10/3 LoseLGNDZ / S&P
LGNDZ unavailable / -4.60%
LoseLGNDZ / S&P
LGNDZ unavailable / 15.97%
LoseLGNDZ / S&P
-41.56% / 42.23%
2021-Q41/3 LoseLGNDZ / S&P
LGNDZ unavailable / 11.03%
WinLGNDZ / S&P
47.68% / 15.00%
LoseLGNDZ / S&P
LGNDZ unavailable / 96.40%
2021-Q30/3 LoseLGNDZ / S&P
LGNDZ unavailable / 0.58%
LoseLGNDZ / S&P
LGNDZ unavailable / 10.77%
LoseLGNDZ / S&P
LGNDZ unavailable / 69.42%
2021-Q20/3 LoseLGNDZ / S&P
LGNDZ unavailable / 8.55%
LoseLGNDZ / S&P
LGNDZ unavailable / 6.58%
LoseLGNDZ / S&P
LGNDZ unavailable / 51.81%
2021-Q10/3 LoseLGNDZ / S&P
LGNDZ unavailable / 6.17%
LoseLGNDZ / S&P
LGNDZ unavailable / -1.06%
LoseLGNDZ / S&P
LGNDZ unavailable / 7.39%
2020-Q41/3 LoseLGNDZ / S&P
LGNDZ unavailable / 12.15%
WinLGNDZ / S&P
35.98% / -3.72%
LoseLGNDZ / S&P
-100.57% / -33.42%
2020-Q30/3 LoseLGNDZ / S&P
LGNDZ unavailable / 8.93%
LoseLGNDZ / S&P
LGNDZ unavailable / -2.04%
LoseLGNDZ / S&P
-100.00% / -27.10%
2020-Q20/3 LoseLGNDZ / S&P
LGNDZ unavailable / 20.54%
LoseLGNDZ / S&P
LGNDZ unavailable / -0.46%
LoseLGNDZ / S&P
-101.23% / -27.11%
2020-Q10/3 LoseLGNDZ / S&P
LGNDZ unavailable / -19.60%
LoseLGNDZ / S&P
LGNDZ unavailable / 3.47%
LoseLGNDZ / S&P
-106.91% / -14.75%
2019-Q41/3 LoseLGNDZ / S&P
LGNDZ unavailable / 9.07%
LoseLGNDZ / S&P
-52.17% / 5.36%
WinLGNDZ / S&P
434.40% / 2.99%
2019-Q31/3 LoseLGNDZ / S&P
LGNDZ unavailable / 1.70%
LoseLGNDZ / S&P
LGNDZ unavailable / 5.02%
WinLGNDZ / S&P
284.68% / 0.21%
2019-Q21/3 LoseLGNDZ / S&P
LGNDZ unavailable / 4.30%
LoseLGNDZ / S&P
LGNDZ unavailable / 6.64%
WinLGNDZ / S&P
551.54% / 8.65%
2019-Q11/3 LoseLGNDZ / S&P
LGNDZ unavailable / 13.65%
LoseLGNDZ / S&P
LGNDZ unavailable / 8.12%
WinLGNDZ / S&P
1557.01% / 14.29%
2018-Q42/3 LoseLGNDZ / S&P
LGNDZ unavailable / -13.52%
WinLGNDZ / S&P
78.21% / 9.05%
WinLGNDZ / S&P
1024.53% / 18.23%
2018-Q31/3 LoseLGNDZ / S&P
LGNDZ unavailable / 7.71%
LoseLGNDZ / S&P
LGNDZ unavailable / 10.21%
WinLGNDZ / S&P
959.42% / 19.06%
2018-Q21/3 LoseLGNDZ / S&P
LGNDZ unavailable / 3.43%
LoseLGNDZ / S&P
LGNDZ unavailable / 9.03%
WinLGNDZ / S&P
1181.58% / 14.46%
2018-Q10/3 LoseLGNDZ / S&P
LGNDZ unavailable / -0.76%
LoseLGNDZ / S&P
LGNDZ unavailable / 7.68%
LoseLGNDZ / S&P
LGNDZ unavailable / 12.46%
2017-Q41/3 LoseLGNDZ / S&P
LGNDZ unavailable / 6.64%
WinLGNDZ / S&P
29.48% / 7.03%
LoseLGNDZ / S&P
LGNDZ unavailable / 13.82%
2017-Q31/3 LoseLGNDZ / S&P
LGNDZ unavailable / 4.48%
LoseLGNDZ / S&P
LGNDZ unavailable / 5.68%
WinLGNDZ / S&P
130.00% / 17.57%
2017-Q20/3 LoseLGNDZ / S&P
LGNDZ unavailable / 3.09%
LoseLGNDZ / S&P
LGNDZ unavailable / 4.83%
LoseLGNDZ / S&P
-96.01% / 17.74%
2017-Q10/3 LoseLGNDZ / S&P
LGNDZ unavailable / 6.07%
LoseLGNDZ / S&P
LGNDZ unavailable / 3.67%
LoseLGNDZ / S&P
-101.65% / 13.32%
2016-Q41/3 LoseLGNDZ / S&P
LGNDZ unavailable / 3.82%
WinLGNDZ / S&P
51.53% / 2.09%
LoseLGNDZ / S&P
-100.74% / 7.05%
2016-Q30/3 LoseLGNDZ / S&P
LGNDZ unavailable / 3.85%
LoseLGNDZ / S&P
LGNDZ unavailable / 0.20%
LoseLGNDZ / S&P
-97.21% / -3.15%

Dividend-reinvested, split-adjusted total return

Calculation rules

window
Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
return Basis
Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
point Rule
Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
frequency
Quarter endpoints only.
fundamentals
Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
non Scoring

Snapshot captured 2026-09-24.